Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | BMC Genomics

Fig. 2

From: The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence

Fig. 2

Phylogenetic relationships of twelve T. parva isolates. Genomic distances are measured in SNPs detected within the coding region of 200 randomly selected genes. Support was obtained from 500 bootstrap replicates. Represented isolates include T. parva stocks analyzed in this study, and the additional stocks described by Hayashida et al. in [10], namely the cattle-derived T. parva parasite stocks "Entebbe", "Katumba", "Nyakizu", "ChitongoZ2", "KateteB2", "KiambuZ464", and "MandaliZ22", as well as the African Cape buffalo-derived stocks "Lawrencei", and "Z5E5". Stocks are labeled according to country of origin: northern end of the distribution -Kenya, Uganda and Rwanda (dark green); north-central region –Tanzania (teal); central region –Zambia (blue). The three vaccine isolates are shown (bold-italics font)

Back to article page